News Summary
NeutralMorgan Stanley beat Q3 earnings estimates with $3.03 EPS (vs. $2.91 est.) and $20.3B revenue, driven by strong equities trading (+41% YoY) and record wealth management results ($8.43T AUM, +19.5% YoY). However, the stock declined 3% post-earnings amid analyst caution, and the firm faces a Delaware lawsuit alleging years of lax anti-money laundering oversight by current and former directors.
Red flags
- •Delaware Chancery Court lawsuit alleging failure to oversee AML controls for years, involving former CEO Gorman
- •Stock declined 3% despite earnings beat; Wells Fargo analyst called results 'good, not great'
- •Data breach settlement ($6.5M) over compromised customer personal information
- •Erste Group downgraded MS from 'buy' to 'hold' on October 8
Funds Buying (3)
| Fund | Manager | Shares Held | ∆ Shares | Position Value | % of Fund | QoQ | Status |
|---|---|---|---|---|---|---|---|
| Viking Global | Andreas Halvorsen | 1.9M | +313K | $364M | 1.1% | +19% | Existing |
| Point72 | Steve Cohen | 1.1M | +867K | $209M | 0.3% | +353% | Existing |
| Maverick Capital | Lee Ainslie | 12K | +12K | $2M | <0.1% | — | NEW |
Shares Held and Position Value reflect total quarter-end holdings. ∆ Shares is the change from the prior quarter. % of Fund is the position's share of the fund's reported equity portfolio — it drives the size weighting in the conviction score.
Portfolio Context
Where MS ranks in each buying fund's book, and the positions immediately around it. What a holding sits next to often says more about the thesis than the position size does.
position #37 of this fund's book
- 34BIOMARIN PHARMACEUTICAL INC$430M
- 35FEDEX FGHT HLDG CO INC$424M
- 36GENUINE PARTS CO$376M
- 37MORGAN STANLEY$364M
- 38ZEBRA TECHNOLOGIES CORPORATI$355M
- 39EQUITABLE HLDGS INC$348M
- 40AGILENT TECHNOLOGIES INC$302M
Values are quarter-end position sizes. Shown only for funds where MS ranks inside their 40 largest equity positions — below that, neighbouring names carry no signal. Adjacency is an inference about a fund's reasoning, not a disclosure of it.
Insider Activity
| Name | Title | Type | Shares | Price | Value | Filed | Src |
|---|---|---|---|---|---|---|---|
| Miscik Judith A | — | SELL | 2K | $183.21 | $0.45M | 2026-11-06 | ↗ |
Congressional Trading
No trades dated since Jul 1, 2026.
Earlier trades (1) — dated outside this quarter's window, not counted in the badges
| Member | Chamber | State | Type | Amount Range | Transaction Date | Filed | Src |
|---|---|---|---|---|---|---|---|
| Alan Armstrong | senate | — | BUY | $1,001 - $15,000 | 2026-03-27 | 2026-07-21 | ↗ |
Periodic Transaction Reports filed under the STOCK Act. Amounts are disclosed as ranges, not exact dollar figures. Members often file weeks or months after trading, so trades are placed by transaction date: the badges above count trades dated since Jul 1, 2026.